IBCA Stock UPDATES Intervest Bancshares (IBCA) 9.58 09/12/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intervest Bancshares (IBCA) 9.58 $IBCA

23.3% Return Seen to Date on SmarTrend Intervest Bancshares Call (IBCA)
Comtex SmarTrend(R) - Tue Sep 09, 11:01AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 8 months, Intervest Bancshares has returned 23.34% as of today's recent price of $9.59.

Intervest Bancshares Corporation Announces Repurchase of Outstanding TARP Warrant
Business Wire - Wed Sep 03, 10:52AM CDT
Intervest Bancshares Corporation (the "Company" (Nasdaq:IBCA), the holding company for Intervest National Bank, announced today that it has repurchased the warrant that had been issued to the U.S. Department of the Treasury in connection with the Company's participation in the TARP Capital Purchase Program. The Company paid Treasury $2,892,066 to repurchase the warrant, which has been cancelled. The Company had originally issued the warrant, which permitted Treasury to purchase up to 691,882 shares of the Company's common stock at an exercise price of $5.42 per share, on December 23, 2008. The Company repurchased all of the shares of TARP preferred stock in June and August of 2013. With the repurchase of the warrant, there are no other investments from the Company's participation in TARP that remain outstanding.

Intervest Bancshares Up 23.7% Since SmarTrend Uptrend Call (IBCA)
Comtex SmarTrend(R) - Tue Sep 02, 9:39AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 8 months, Intervest Bancshares has returned 23.73% as of today's recent price of $9.62.

INVESTOR ALERT - Intervest Bancshares Corp.: The Law Offices of Vincent Wong Investigates the Sale of Intervest Bancshares Corp. to Bank of the Ozarks, Inc. - IBCA
PR Newswire - Mon Aug 18, 4:14PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Intervest Bancshares Corporation (NasdaqGS: IBCA) ("Intervest" in connection with the sale of the Company to Bank of the Ozarks, Inc. (NasdaqGS: OZRK).

Lifshitz & Miller Law Firm Announces Investigation of Endocyte, Inc., EVOQ Properties Inc., Fortegra Financial Corporation, Intervest Bancshares Corporation and L-3 Communications Holdings, Inc.
PR Newswire - Mon Aug 18, 12:52PM CDT
Endocyte, Inc.

Shares of IBCA Up 23.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Aug 18, 11:12AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 8 months, Intervest Bancshares has returned 23.34% as of today's recent price of $9.59.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Intervest Bancshares Corp. and Its Board of Directors In Connection With the Sale of the Company to Bank of the Ozarks, Inc. -- IBCA
Business Wire - Thu Aug 14, 1:27PM CDT
Levi & Korsinsky is investigating the Board of Directors of Intervest Bancshares Corporation ("Intervest" or "the Company" (NasdaqGS:IBCA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bank of the Ozarks, Inc. (NasdaqGS:OZRK).

INTERVEST BANCSHARES SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Bank of the Ozarks
Business Wire - Thu Aug 14, 11:38AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Intervest Bancshares Corp. ("Intervest" (NasdaqGS: IBCA) concerning the merger with Bank of the Ozarks, Inc. Under the terms of the definitive agreement, valued at approximately $228.5 million, Intervest shareholders will receive common shares of Bank of the Ozarks stock pursuant to the ten day average closing stock price as of the fifth business day prior to the closing date, with a minimum and maximum price of $23.95 and $39.91.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Intervest Bancshares Corporation In Connection With The Proposed Sale Of The Company To Bank of the Ozarks, Inc.
Business Wire - Tue Aug 12, 5:10PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Intervest Bancshares Corporation ("Intervest" or the "Company" (NASDAQ: IBCA) relating to the proposed buyout of the Company by Bank of the Ozarks, Inc. ("Ozarks" .

Intervest Bancshares Shares Up 21.7% Since SmarTrend's Buy Recommendation (IBCA)
Comtex SmarTrend(R) - Mon Aug 04, 9:13AM CDT
SmarTrend identified an Uptrend for Intervest Bancshares (NASDAQ:IBCA) on December 30th, 2013 at $7.78. In approximately 7 months, Intervest Bancshares has returned 21.67% as of today's recent price of $9.46.

Nasdaq stocks posting largest volume increases
AP - Fri Aug 01, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Nasdaq stocks posting largest percentage increases
AP - Fri Aug 01, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Bank of the Ozarks, Inc. and Intervest Bancshares Corporation Enter into Definitive Agreement and Plan of Merger
Business Wire - Thu Jul 31, 4:25PM CDT
Bank of the Ozarks, Inc. (NASDAQ: OZRK) and Intervest Bancshares Corporation (NASDAQ: IBCA) jointly announced today the signing of a definitive agreement and plan of merger ("Agreement" whereby Bank of the Ozarks, Inc. ("Company" will acquire Intervest Bancshares Corporation ("Intervest" and its wholly-owned bank subsidiary Intervest National Bank ("Intervest Bank" , with offices in Florida and New York, in an all-stock transaction. According to the terms of the Agreement, the Company will acquire all of the outstanding common stock of Intervest in a transaction valued at approximately $228.5 million, less the amount paid by Intervest to cash out all outstanding stock options, stock appreciation rights and stock warrants, and subject to other potential adjustments. Closing of the transaction is expected to be immediately accretive to the Company's book value per common share and its tangible book value per common share. The transaction is also expected to be accretive to the Company's diluted earnings per common share for the first twelve months after the transaction closes and thereafter.

Intervest Bancshares Corporation Reports 2014 Second Quarter Earnings Increase by 79% to $5.7 Million or $0.26 Per Share
Business Wire - Wed Jul 16, 7:00AM CDT
Intervest Bancshares Corporation (IBC) (NASDAQ-GS:IBCA), parent company of Intervest National Bank (INB), today announced that its net earnings for the second quarter of 2014 (Q2-14) increased 79% to $5.7 million, or $0.26 per share, from $3.2 million, or $0.14 per share, for the second quarter of 2013 (Q2-13). For the first half of 2014 (6mths-14), net earnings increased 44% to $9.6 million, or $0.43 per share, from $6.6 million, or $0.30 per share, for the first half of 2013 (6mths-13). IBC also announced that its Board of Directors declared a quarterly dividend of $0.05 per common share payable on August 26, 2014 to shareholders of record at the close of business August 15, 2014.

Intervest Bancshares Corporation Announces Termination of Regulatory Agreement with the Federal Reserve Bank of New York
Business Wire - Thu Mar 13, 10:10AM CDT
Intervest Bancshares Corporation (the "Company" (Nasdaq: IBCA), the holding company for Intervest National Bank (the "Bank" , announced today that actions taken by the Company have led to the satisfaction of all of the provisions of the Formal Agreement dated January 14, 2011 between the Bank and the Federal Reserve Bank of New York (the "FRBNY" , and that the FRBNY was terminating that agreement. The FRBNY based its decision on the results of its most recent inspection as well as documentation provided by the Company under the terms of the agreement. The Bank's Formal Agreement with the Office of the Comptroller of the Currency had been terminated in March of last year. As a result, neither the Company nor the Bank is any longer subject to any formal or informal regulatory agreement.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

DarioHealth Eyes Growth with Rising Revenue and Reduced Costs

Updated Category News Views 39

Quarterly Earnings Reflect Strategic Forward Movement This quarter, DarioHealth (NASDAQ: DRIO) decided to crank up the volume on its long-haul strategy. They've managed a respectable 6% revenue increase over last year, clocking in at $5.3 million for the third quarter of 2026. It's a slight nudge up from the previous quarter too, where they sat at $5.2 million. Not...

Continue Reading
Aflac Boosts 2027 Dividend, Balancing Growth & Stability

Updated Category News Views 107

Dividend Hike: A Sign of Strength When a company like Aflac, with its sprawling presence both in the U.S. and Japan, decides to hike its dividend, it says a lot more than any quarterly report ever could. They just announced a 4.9% bump in the first quarter 2027 dividend, pushing it to $0.64 per share. You better believe this isn't just a pat on the back for their...

Continue Reading
HelloNation Elevates Contractors' Expertise at PHCC NC

Updated Category News Views 10

Times are changing, and the digital landscape keeps morphing—who can keep up? That's exactly what's on the agenda as McKenzie Finkhousen and Alton Baird lead HelloNation into the 2026 PHCC of NC Annual Meeting. This ain't just another LinkedIn meet-up—this is a proper gathering of minds in plumbing, heating, and cooling biz right at Harrah's Cherokee Casino Resort....

Continue Reading
Trusted Space Joins Forces with Falcon ExoDynamics

Updated Category News Views 33

Revolutionizing Space Autonomy with a Strategic Acquisition Sometimes, the stars align, and you've got a game-changer in the space domain. That's exactly what's cooking with Trusted Space's acquisition of Falcon ExoDynamics. What we're witnessing here is not just a merger—it's a seismic shift in how national security is handled in space. Autonomy: The Backbone of Modern...

Continue Reading
Health In Tech's Rocky Q3: Navigating Losses and Opportunities

Updated Category News Views 22

Signs of Optimism Amidst Financial Struggles Health In Tech is wading through the choppy waters of its Q3 2026 financial results—revenue came in at $6.6 million, down from $8.5 million the previous year. Seems like their investments are all geared up, but the sails aren’t quite catching wind yet. That said, their contracted revenue strutted to $32.7 million for the...

Continue Reading
Automated Doggy Massage: Invention Eyes Market Entry

Updated Category News Views 36

From Idea to Relaxed Tails: Enter THE PAW FREE SCRATCHER Strolling along the bustling streets of Pittsburgh, it's the kind of idea that hits you when you least expect it. The endless days spent scratching your furry buddy, only to realize you're the one more tuckered out. Some inventive soul from Puyallup, Washington, decided to tackle this furry fatigue head-on. They've...

Continue Reading
GFL's Big Share Conversion: Impact and Implications

Updated Category News Views 102

Unpacking GFL Environmental's Share Conversion Here's a doozy straight from the gritty world of finance: GFL Environmental Inc. (NYSE: GFL) has announced a hefty conversion of Series A Preferred Shares into a whopping 6,219,896 subordinate voting shares. That's right, those Series A Preferred Shares, helmed by HPS Investment Partners, LLC, are now converted and sold in a...

Continue Reading
Avionics Market To Hit $84B by 2031: Trend Insights

Updated Category News Views 25

The Flight Path to $84 Billion If there's one thing that'll get the adrenaline pumping for aerospace investors, it's hearing that the avionics market is poised to skyrocket from $61.08 billion in 2026 to a hefty $84.32 billion by 2031. That's not chump change, folks. This anticipated growth at a 6.7% compound annual growth rate signals a bustling market hungry for...

Continue Reading
Mark Isham: Recognizing the Voice Behind Award Nomination

Updated Category News Views 74

What's in a Name? Mark Isham Earns His Spotlight Hollywood’s buzz these days has less to do with the usual blockbuster glitter and more with a singular name cresting the scene: Mark Isham. You may not see his name in lights, and yet it’s blaring behind every soundtrack that brings a film to life. This time around, he's in the spotlight not for composing an...

Continue Reading
EDB Bolsters AI Governance With Strategic Expertise

Updated Category News Views 125

EDB’s Strategic Move in AI Governance EnterpriseDB (EDB) is throwing some serious weight behind their AI governance strategy by bringing in top-notch talent from CMRD. The buzz? This team didn’t just descend in a parachute—they already have their fingerprints all over the audit infrastructure of EDB’s governance solution. Now, they're officially joining EDB’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Lattice Semiconductor's New CEO Fuels Stock Surge

Updated Category News Views 98

Lattice Semiconductor Welcomes New Leadership Lattice Semiconductor Corporation (NASDAQ: LSCC) is seeing a notable rise in its share price today. This increase comes in the wake of Ford Tamer being appointed as the new CEO, a decision that has generated optimism among investors. Ford Tamer's Background Ford Tamer arrives with a deep well of experience. He previously held...

Continue Reading
UBS Downgrades Zurich Insurance: Concerns and Market Impact

Updated Category News Views 368

UBS's Downgrade Impact on Zurich Insurance Shares Recently, shares of Zurich Insurance Group (SIX: ZURN) experienced a notable decline after UBS analysts issued a downgrade, changing the stock's rating from 'neutral' to 'sell.' This decision has sent ripples through investor circles and raised concerns among shareholders about the company's future financial performance....

Continue Reading
Annexon Biosciences: Pioneering Neuroinflammatory Treatments

Updated Category News Views 94

Annexon Biosciences to Showcase Latest Developments at Health Care Conference BRISBANE, Calif. — Annexon, Inc. (NASDAQ: ANNX), a pioneering biopharmaceutical company focused on innovative therapies for classical complement-mediated neuroinflammatory conditions, has announced that Douglas Love, the president and chief executive officer, will discuss the company’s...

Continue Reading
Stock Market Update: Marvell, Dell, and Others Face Declines

Updated Category News Views 157

Market Overview and Key Stock Movements On this recent trading session, U.S. stock futures depicted a downward trend, with the Dow futures dropping over 100 points early on. Marvell Technology Inc. Results Shares of Marvell Technology, Inc. (NASDAQ: MRVL) saw a significant drop in pre-market trading after the company provided third-quarter sales guidance that fell short...

Continue Reading
Wolfspeed, Inc. (WOLF) Investors Seek Compensation through Class Action

Updated Category News Views 154

Wolfspeed, Inc. Faces Class Action Lawsuit from Investors Levi & Korsinsky, LLP has announced a class action lawsuit on behalf of investors in Wolfspeed, Inc. This legal action concerns allegations of securities fraud that resulted in significant losses for shareholders. Understanding the Lawsuit The lawsuit primarily seeks to address losses incurred by investors...

Continue Reading